| scholarly article | Q13442814 |
| P356 | DOI | 10.1128/AAC.26.1.22 |
| P953 | full work available at URL | https://europepmc.org/articles/PMC179909 |
| https://europepmc.org/articles/PMC179909?pdf=render | ||
| https://journals.asm.org/doi/pdf/10.1128/AAC.26.1.22 | ||
| P932 | PMC publication ID | 179909 |
| P698 | PubMed publication ID | 6089651 |
| P2093 | author name string | L. Nilsson | |
| S. Anséhn | |||
| P2860 | cites work | New rapid bioassay of gentamicin based on luciferase assay of extracellular ATP in bacterial cultures | Q36476109 |
| In Vitro Studies with 5-Fluorocytosine | Q37185781 | ||
| Modern aspects of testing azole antifungals | Q39093405 | ||
| Heterogeneity of action of mechanisms among antimycotic imidazoles | Q39855440 | ||
| Primary site of action of ketoconazole on Candida albicans | Q39857229 | ||
| Studies on the mechanism of action of miconazole: effect of miconazole on respiration and cell permeability of Candida albicans | Q40943187 | ||
| Comparison of miconazole- and ketoconazole-induced release of K+ from Candida species | Q41556224 | ||
| Effects of pH on the Activity of Ketoconazole Against Candida albicans | Q41822584 | ||
| Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro | Q42129126 | ||
| Effect of culture media on the antifungal activity of miconazole and amphotericin B methyl ester | Q48361725 | ||
| Mechanisms of action of the antimycotic imidazoles | Q70154156 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacology | Q128406 |
| bioluminescence | Q179924 | ||
| tioconazole | Q260326 | ||
| Candida albicans | Q310443 | ||
| luminescent measurements | Q73355458 | ||
| P1104 | number of pages | 4 | |
| P304 | page(s) | 22-25 | |
| P577 | publication date | 1984-07-01 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Direct membrane-damaging effect of ketoconazole and tioconazole on Candida albicans demonstrated by bioluminescent assay of ATP | |
| P478 | volume | 26 |
| Q46813857 | ATP bioluminescence assay for estimation of microbial populations of fresh-cut melon |
| Q44387146 | Binding, internalisation and degradation of histatin 3 in histatin-resistant derivatives of Candida albicans |
| Q43637578 | Bioluminescence ATP assay for estimating total plate counts of surface microflora of whole cantaloupe and determining efficacy of washing treatments |
| Q24290527 | Candidacidal activities of human lactoferrin peptides derived from the N terminus |
| Q35912775 | Differentially expressed proteins in derivatives of Candida albicans displaying a stable histatin 3-resistant phenotype |
| Q34143941 | Endogenous reactive oxygen species is an important mediator of miconazole antifungal effect |
| Q43755803 | Enhanced antifungal activity of ketoconazole by Euphorbia characias latex against Candida albicans |
| Q39827653 | Entry of ketoconazole into Candida albicans |
| Q39785452 | Fungicidal mechanism of action of D0870 against Cryptococcus neoformans under acidic conditions. |
| Q47550728 | Guidelines and recommendations on yeast cell death nomenclature. |
| Q44604619 | Increase of activity of tioconazole against resistant microorganisms by the addition of butylated hydroxyanisole |
| Q39829159 | Is it morphologic type or physiologic state that governs susceptibility of Candida albicans to clotrimazole kill? |
| Q54395597 | Leakage of intracellular UV materials of high hydrostatic pressure-injured Escherichia coli O157:H7 strains in tomato juice. |
| Q46306291 | Membrane damage and viability loss of Escherichia coli K-12 and Salmonella enteritidis in liquid egg by thermal death time disk treatment |
| Q52586820 | Membrane damage and viability loss of Escherichia coli K-12 in apple juice treated with radio frequency electric field. |
| Q42920974 | Modes of action of the new arylguanidine abafungin beyond interference with ergosterol biosynthesis and in vitro activity against medically important fungi |
| Q24617248 | Overview of medically important antifungal azole derivatives |
| Q46485424 | Plasma membrane damage to Candida albicans caused by chlorine dioxide (ClO2). |
| Q73092074 | Protective effect of iridals from saponin injury in Candida albicans cells |
| Q48190309 | Real-Time Imaging of the Azole Class of Antifungal Drugs in Live Candida Cells. |
| Q34005242 | Released ATP is an extracellular cytotoxic mediator in salivary histatin 5-induced killing of Candida albicans |
| Q33980976 | Salivary histatin 5 and human neutrophil defensin 1 kill Candida albicans via shared pathways. |
| Q41682327 | Synergistic reduction of toluylene blue induced by acetaldehyde and menadione in yeast cell suspension: Application to determination of yeast cell activity |
| Q37903581 | Tioconazole. A review of its antimicrobial activity and therapeutic use in superficial mycoses |
| Q35117932 | Use of amphotericin B with azole antifungal drugs: what are we doing? |
Search more.